NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.00% | 38.44% | -952.21% | -153.52% | -612.70% |
| Total Depreciation and Amortization | -2.24% | -7.99% | -9.34% | -12.31% | -13.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.24% | 2.30% | 548.12% | 1,347.19% | 4,287.77% |
| Change in Net Operating Assets | 3,223.05% | 161.88% | 8.61% | 46.68% | -107.12% |
| Cash from Operations | 50.43% | 23.70% | 0.02% | 21.43% | -15.44% |
| Capital Expenditure | 24.72% | -9.24% | 5.66% | -242.16% | -164.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -99.21% | -99.21% | -99.21% |
| Cash Acquisitions | -- | 100.00% | 100.00% | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 22.87% | 12.19% | -155.51% | -159.28% | -168.01% |
| Total Debt Issued | -- | 25,800.00% | -- | 597.42% | -100.00% |
| Total Debt Repaid | -326.19% | -270.77% | -123.29% | -97.67% | 56.56% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1,612.50% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -150.00% | 32.92% | 14.52% | -56.72% | -51.39% |
| Cash from Financing | 10.02% | 27.13% | 69.13% | 59.54% | 41.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 675.62% | 1,483.76% | 126.03% | -7.18% | -115.19% |